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Abstract
Background: Cross-reactivity between soybean allergens and bovine caseins has been previously reported. In this study we
aimed to map epitopes of the major soybean allergen Gly m 5 that are co-recognized by casein specific antibodies, and to
identify a peptide responsible for the cross-reactivity.
Methods: Cow’s milk protein (CMP)-specific antibodies were used in different immunoassays (immunoblotting, ELISA, ELISA
inhibition test) to evaluate the in vitro recognition of soybean proteins (SP). Recombinant Gly m 5 (a), a truncated fragment
containing the C-terminal domain (a-T) and peptides of a-T were obtained and epitope mapping was performed with an
overlapping peptide assay. Bioinformatics tools were used for epitope prediction by sequence alignment, and for modelling
the cross-recognized soy proteins and peptides. The binding of SP to a monoclonal antibody was studied by surface
Plasmon resonance (SPR). Finally, the in vivo cross-recognition of SP was assessed in a mouse model of milk allergy.
Results: Both a and a-T reacted with the different CMP-specific antibodies. a-T contains IgG and IgE epitopes in several
peptides, particularly in the peptide named PA. Besides, we found similar values of association and dissociation constants
between the a-casein specific mAb and the different milk and soy components. The food allergy mouse model showed that
SP and PA contain the cross-reactive B and T epitopes, which triggered hypersensitivity reactions and a Th2-mediated
response on CMP-sensitized mice.
Conclusions: Gly m 5 is a cross-reactive soy allergen and the a-T portion of the molecule contains IgG and IgE
immunodominant epitopes, confined to PA, a region with enough conformation to be bound by antibodies. These findings
contribute to explain the intolerance to SP observed in IgE-mediated CMA patients, primarily not sensitised to SP, as well as
it sets the basis to propose a mucosal immunotherapy for milk allergy using this soy peptide.
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Introduction
Food allergy is an increasing health care concern. Cow’s milk
protein (CMP) is the leading cause of food allergy in children
younger than 3 years in many regions, including our country [1,2].
This is reflected by most of the position papers and guidance with
statements and recommendations for food allergy that are focused
on CMP allergy (CMA) [3].
If symptoms were relevant and CMA were suspected, a
diagnostic dietary elimination of CMP should be initiated for a
certain period of time (days to 4 weeks) [4,5]. Once a diagnosis of
allergy to milk proteins has been confirmed, it is important to
avoid CMP and to ensure a healthy balanced diet that promotes
an adequate child growth and development. Depending on the age
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and other food allergies a restriction or milk free diet is indicated
as therapy.
Soy-based formulas have been available for almost 100 years
and have been widely used as a milk substitute in children
intolerant to cow’s milk protein-based formula [6]. However, there
are some indications and contraindications of soy formulas since
gastrointestinal reactions, including hypersensitivity, have been
described for more than 50 years [7], and because of the
nutritional quality of soy proteins [8]. More recently, it has been
reported that a small proportion of children with IgE and non IgE-
mediated milk allergy develop a clinical intolerance to soy-protein-
based formula during the restriction treatment, which may be
explained by cross-reactivity once milk contamination has been
discarded [6,9,10]. We focused our work in investigating the cross-
recognition between CMP and soy components. We identified
bovine caseins, the main allergens of milk [11,12], and the soybean
Gly m 6 G4 as cross-reactive allergens [13–15]. The analysis of a
soy variety that naturally lacks the Gly G4 led us to detect that a
residual cross-reactivity may lie on Gly m 5.0101, the a subunit of
the b-conglycinin. Besides, both seed proteins have been
characterized as allergens in patients with IgE-mediated atopic
dermatitis [16], food allergy [17,18], asthma [19] and anaphylaxis
[20,21]. Therefore, we propose that the clinical intolerance
observed in a restricted proportion of milk allergic patients, with
documented IgE specific to milk proteins, may be due to the
presence of these relevant cross-reactive allergens in soy protein-
based formulas.
In this study, we immunochemically and biologically charac-
terized the a subunit of b-conglycinin, and a C-terminal fragment
called a-T, containing putative cross-reactive epitopes with bovine
caseins. Using bioinformatic, immunochemical and biological
tools we demonstrated the presence of B epitopes on this molecule,
and we identified a polypeptide that contains critical epitopes for
cross-recognition. The results presented here may shed some light
to understand the concomitant soy allergy that occurs in infants
with IgE-mediated CMA, and not primarily sensitised to soy
proteins. However, and more challenging for us, the identification
of cross-reactive B and T epitopes would set the basis to propose a
soy-based immunotherapy for milk and soy allergies, taking
advantage of the lower immunogenicity of soy proteins.
Methods
Protein Extracts
Cow’s milk protein extract was prepared from skimmed dry
milk (Svelty, Nestle). Proteins were extracted with phosphate saline
buffer pH 7.4 (10 mg/ml) and filtered. Soy protein (SP) extract
was prepared from Glycine max. L merr genotype Asgrow seeds as
described previously [14]. Briefly, proteins were extracted from
crushed seeds with 0.01N NaHCO3 at 90uC. The extract was
centrifuged (2,5006g-20 min at room temperature) and lipids
were extracted with chloroform (overnight at 4uC). Finally, the
extract was dialyzed against distilled water. The total protein
content was quantified with the Bicinchoninic acid kit (Pierce BCA
Protein Assay), using bovine serum albumin (BSA) as standard.
Production of the a Subunit of b-conglycinin and a-T
Fragment in Escherichia coli
The cDNA coding sequence for a (GenBank: X17698) was
obtained by PCR amplification of cDNA library from developing
Glycine max L. Merr. seeds [22]. pET-ma and pET a-T [22] were
transformed into Escherichia coli strain BL21(DE3) for protein
expression of a subunit of b-conglycinin (a) and a-T, its truncated
polypeptide containing three alpha helix and one cupin domain
typical of the cupin superfamily [23]. Production and purification
of the recombinant proteins are described elsewhere [14].
PA and PN Peptide Constructs, Expression and
Purification
The oligonucleotide primers used for expression of peptides A
and N (PA and PN, amino acids 357–418 and amino acids 438–
499 of the pre-pro a subunit, respectively) were: F-pepA
(CACCCTGTTTAGTAGAGAGGAAG) and R-pepA (TCACT-
TGTTGGAGTAGATGGG), F-pepN (CACCATCTTCCTCA-
GTATTGTGG) and R-pepN (TCATTCGGCTCTATATT-
TCCGC). Amplified PCR products were cloned directionally into
pENTR/D TOPO (Life Technology, S.A. Buenos Aires, Argen-
tina), and then transferred to pDEST destination vector for
expression [24]. E. coli BL21 Codon Plus competent cells
transformed with the construct ‘‘pDEST His-PA’’ and ‘‘pDEST
His-PN’’, were induced for protein expression. Recombinant
proteins were purified as described previously [14] and protein
concentration was determined by BCA protein assay.
Production of Polyclonal and Monoclonal Antibodies
CMP- and SP-specific polyclonal antisera obtained in rabbit
using complete or incomplete Freund’s Adjuvant, and a specific a-
casein monoclonal antibody (1D5 mAb) were all obtained as
described in Docena et al [11]. 1D5 mAb was biotinylated for the
SPR biosensor assay. Briefly, 1D5 mAb (1 mg/ml in 0.1M borate
buffer, pH 8.8) was incubated with 10 mg/ml solution of N-
hidroxisuccinimide-biotin in DMSO (250 mg:1 mg of biotin:mAb
ratio) for 4 h at room temperature. The biotinylated mAb was
desalted by dialysis against PBS and biotinylation was assessed by
ELISA using alkaline phosphatase-conjugated streptavidin (Sigma
Aldrich, St Louis, MO). For this assay wells were coated with
CMP (1 mg/well), and after blocking, dilutions (1:100 to
1:100,000) of the biotinylated-1D5 mAb were added, followed
by the alkaline phosphatase-conjugated streptavidin (1:4,000).
Color was developed with p-nitrophenylphosphate in buffer
pH 9.6, and optical density (OD) at 405 nm was measured in an
ELISA reader (Sirio S SAECS, Roma, Italy).
Patient Sera Used for In Vitro Characterization of the
Allergen Content
Sera obtained from 15 atopic children (ages ranging from 3
months to 10 years, mean age: 4.5 years) with documented IgE-
mediated CMA by history, and recruited for other studies, were
used. Double blind placebo-controlled food challenge was not
done since it is not performed in Argentina for diagnosis. Patients
showed clinical pictures of immediate reactions associated to the
ingestion of milk or milk-derived products (vomiting, diarrhoea,
dermatitis, bronchospasm, urticaria and rhinorrhea). Histories
showed no evidence of soybean sensitization. CMP-specific IgE
antibodies were detected by immunoblotting, ELISA and EAST
(Class 2 or higher) as described previously [12]. Skin prick test with
commercial extracts (CMP and common environmental allergens)
(Alergo Pharma, Buenos Aires, Argentina) was performed.
Histamine (10 mg/ml) and PBS (pH 7.4) were used as positive
and negative control, respectively.
Besides, sera from 20 subjects (age- and sex-matched) with no
history of food allergy, no clinical manifestations after ingestion of
CM, with normal level of serum total IgE according to age, and no
specific serum IgE antibodies were used as negative controls.
A Soy Peptide Responsible for Allergy in Mouse
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SDS PAGE and Immunoblotting
SDS-PAGE and immunoblotting were performed as described
before [14]. Samples prepared in sample buffer were loaded on
gels (10–20 mg/lane for CMP or SP, or 7–10 mg/lane for the
recombinant proteins) and electrotransferred onto nitrocellulose
membranes. Membranes were probed with the 1D5 mAb (1:1,500
in TBS-Tween 20), cow’s milk-specific rabbit polyclonal antiserum
(1:1,000 in TBS-Tween 20) for 1 h at 37uC, or with patient sera
(1:4 in blocking buffer) overnight at 4uC, as primary antibody,
followed by the appropriate conjugated secondary antibody which
were: biotinylated goat anti-mouse immunoglobulin G (1:3,000,
Chemicon Int., Temecula, CA), biotinylated mouse monoclonal
antibodies specific to rabbit immunoglobulins (1:3,000, Sigma-
Aldrich, St Louis, MO) and horseradish peroxidase-conjugated
avidin (1:4,000, Sigma-Aldrich, St Louis, MO), or horseradish
peroxidase-conjugated anti-human IgE antibodies (dilution
1:1,000, Sigma Aldrich, St Louis, MO) for 4 h at 37uC. Protein
bands were visualized by enhanced chemiluminescence (ECL Plus,
GE Healthcare, Bucks, UK) according to manufacturer’s instruc-
tions. X-ray-sensitive films (Amersham HypefilmTM MP, GE
Healthcare Limited, Pollarsd Wood, UK) were used and images
were acquired with a Hewlett Packard scanner.
Indirect ELISA for IgE Reactivity
Polystyrene microtiter plates (NUNC, Maxisorp, Denmark)
were coated with 1.25 mg/well of CMP, 0.05 mg/well of SP or
with 0.05 mg/well of a or a-T, in 50 mM carbonate buffer
(pH 9.6). Plates were blocked with 5% horse serum in PBS
(pH 7.4), and the ELISA was carried out using the patient or
negative control sera as primary antibody, as previously described
[11,14]. Cut-off values were statistically obtained (SEM+2 SD)
from the readings of the negative control sera used.
Sequential Competitive ELISA
ELISA plates were coated overnight with 1 mg/well of CMP
and blocked with 5% horse serum in PBS (pH 7.4) for 1 hr at
37uC. CMP-specific rabbit antiserum diluted 1:200,000 in 3%
horse serum in PBS (pH 7.4), or a-casein specific mAb diluted
1:300,000 in the same buffer, were mixed (1:1) with different
concentrations of inhibitors: CMP, a a-T or bovine serum
albumin (BSA) (Sigma Aldrich, St Louis, MO) for 2 h at 37uC.
Then 100 ml of this pre-mixed dilution was added in triplicates to
the antigen-coated wells and incubated for 30 min at 37uC.
Biotinylated mouse monoclonal antibodies specific to rabbit
immunoglobulins (1:3,000, Sigma-Aldrich, St Louis, MO) or
biotinylated goat anti-mouse immunoglobulin G (1:3,000, Che-
micon Int., Temecula, CA) were added for 1 h at 37uC. Finally,
horseradish peroxidase-conjugated avidin (1:3,000, Sigma-Al-
drich, MO, USA) was added (30 min at 37uC) and color was
developed with o-phenylenediamine and 30% H2O2 in 0.1M
citrate-phosphate buffer pH 5.0. Optical density was measured at
492 nm in an ELISA reader. Additionally, 96-well plates were
coated with a or a-T (0.1 mg/well) and blocked. CMP-specific
polyclonal antiserum diluted 1:6,000 was used in the inhibition
mix with same inhibitors. Then, 100 ml of the pre-mixed dilution
was added to the coated wells and developed as described above.
Cross-reactive Epitope Mapping on a-T
Overlapping 15-mer peptides, frame shifted by five residues,
covering the entire aminoacid sequence of a-T were synthesized
on a cellulose membrane (PepSpot JPT Peptide Technologies
GMBH, Germany). Spots membrane-based immunoassay was
carried out by incubation of the blocked membranes with different
primary antibodies (pools of sera containing CMP specific IgE,
CMP-specific rabbit polyclonal antiserum or 1D5 mAb), followed
by the appropriate secondary antibody. Membranes were devel-
oped by chemiluminescence as described above.
Binding Kinetics Analysis Using the BIACORE Assay
Affinity sensor analysis experiments were conducted on an IAsys
Plus apparatus (Affinity Sensors, Saxon Hill, Cambridge, U.K.).
Streptavidin (Sigma Aldrich, USA) (100 mg/ml in acetate buffer,
pH 5.0) was covalently coupled to carboxymethyl dextran sensor
chips (Affinity Sensors, Saxon Hill, Cambridge, U.K.) (5 ng of
protein per cuvette). Then, a solution of 20 mg/ml in saline buffer
of the biotinylated 1D5 mAb (the ligand) was added to the cuvette
during 10 minutes, the antibody excess was removed by adding
1M NaCl and 10 mM acetate buffer at pH 4.5. Binding reactions
with the ligate were carried out in PBS, 0.05% Tween 20 at 25uC,
with constant stirring set up at 90%. Data were collected at
intervals of 0.3 sec. Ligate binding to the immobilized ligand was
monitored at multiple ligate concentrations, ranging 10-fold below
to at least 10-fold above preliminary estimates of equilibrium
dissociation constants (KD) for each reaction. Kinetic and
Scatchard analysis were performed by using the FAST FIT
software (Affinity Sensors, Saxon Hill, Cambridge, U.K.).
Bioinformatics Analysis
Caseins and subunits of soybean b-conglycinin were compared
using bioinformatics tools. The sequences of a (gi:9967357: 543
aa), a9 (gi:15425631: 621 aa) and b (gi: 9967359: 416 aa) subunits
of b-conglycinin, and as1- (gi:162792: 214 aa), as2-
(gi:27806963:222 aa), b- (gi:162931:224 aa) and k- (gi:1228078:
190 aa) caseins were retrieved from the GenBank database.
Several epitope prediction methods available in the B Cell Epitope
Prediction Tools at the Immune Epitope Database (IEDB) [25]
(http://www.immuneepitope.org) were applied. These methods
included Chou & Fasman Beta-Turn Prediction [26], Emini
Surface Accessibility Prediction [27], Karplus & Schulz Flexibility
Prediction [28], Kolaskar & Tongaonkar Antigenicity [29], and
Parker Hydrophilicity Prediction [30]. Peptides identified as
putative epitopes based on these predictions were collected in a
database. A second database was built using overlapping peptides
(15 residues long) of the cow milk and soybean proteins mentioned
above. Both databases were aligned with the BLASTP program
using parameters fixed to short peptides (Expect Value = 20,000,
Score Matrix = PAM30, Word Size = 2, SEG Filter = off) [31] and
a shorter region of a located on the a-T segment, containing most
amino acid coincidences with bovine caseins epitopes, and named
‘‘Peptide A (PA)’’, was selected. We have used MODELLER [32]
to build structural models of a protein based on templates found
with FFAS03 fold assignment method [33]. Three-D models were
assessed using ProsaII [34] and the PyMOL (http://www.pymol.
org) was employed to map a-T and PA on the best 3D models
obtained. Calculation of the electrostatic potential surface was
made with the web-based graphical user interface PBEQ-Solver
[35] and the electrostatic map was visualized in PyMOL.
The hit distribution graph was done to represent those similar
amino acid positions shared by soybean a, a-T, and bovine casein
peptides. The amino acid sequence of 73 peptides of aS1-, as2-, b-
and k-casein, described as T and/or B epitopes (IEDB, (http://
www.immuneepitope.org/), were aligned with a-T sequence by
the ClustalW2 server (http://www.ebi.ac.uk/Tools/msa/
clustalw2/). The hits represent the accumulation of consensus
amino acid in every position of the sequence analyzed. A score of
‘‘3’’ was assigned for conserved aminoacid (identity), ‘‘2’’ for
similar, but not identical amino acids (punctuation over 0.5 on
A Soy Peptide Responsible for Allergy in Mouse
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Gonnet or PAM 250 matrixes), and ‘‘1’’ for slightly similar amino
acids (punctuation below 0.5 on Gonnet or PAM 250 matrixes).
Secondary Structure Prediction
Bioinformatics studies described above allowed us to find out
that the PA fragment has a primary structure alignment with a
fragment of bovine a-casein. Different secondary structure
prediction servers and softwares were used to analyze both
fragments. Prediction programs belong to the Network Protein
Sequence Analysis server [36], which contains SOPM, SOPMA,
Hierarchical Neural Network, GOR I, GOR III, GOR IV, DPM,
DSC, PHD, PREDATOR, SIMPA 96 and Secondary consensus
prediction. Other programs such as CFSSP [37], Jpred [38],
JUFO 3D [39], NetSurfP and Multivariate Linear Regression
Combination were also used. The final secondary structure
prediction was the average of all structures obtained with those
prediction programs. Besides, the alignments were performed
using the BLAST program.
Mice and Experimental Model of IgE-mediated Food
Allergy
Sensitization and Antigenic Challenge. Male 6- to 8-week
old Balb/c mice were purchased from the School of Animal
Sciences, University of La Plata, and kept under pathogen-free
conditions with water and commercial diet provided ad libitum.
Cow’s milk sensitization protocol was carried out as previously
described [15]. Briefly, mice received 6 weekly intragastric (ig)
doses of CMP (20 mg/dose) plus cholera toxin (10 mg/dose)
(Sigma Aldrich, St Louis, MO, USA) in a final volume of 200 ml of
bicarbonate buffer (sensitization group), or CMP (20 mg/dose)
without cholera toxin (control group). Mice were fasted for 2 h
before sensitization, and 3% sodium bicarbonate solution was
given 30 min before the immunization. Ten days following the last
boost mice were ig challenged with different proteins: 20 mg of
CMP, 5 mg of SP or 10 mg of OVA (Sigma-Aldrich, St Louis,
MO, USA) as an unrelated antigen. Additionally, some animals
were sublingual (sl) challenged with 10 mg of purified proteins [b-
lactoglobulin (b-lg), a, a-T, PA or OVA]. Symptoms immediately
triggered after the oral challenge were scored in a blinded manner
by two independent observers.
In vivo evaluation of the allergic state
Assessment of Clinical Signs. Symptoms were observed
30–60 min following the oral challenge, in a blinded fashion by 2
independent researchers, and scored on a scale from 0 to 5. Some
animals received sl 10 mg of recombinant soybean proteins, b-lg
(positive control), or OVA (unrelated negative control), and
elicited symptoms were scored.
Cutaneous Tests. Mice were shaved on both flanks and
subcutaneously injected with 200 mg of CMP, 400 mg of SP, 10 mg
of a, a-T or PA in 50 ml of sterile saline in one flank, and 10 mg of
saline in the other flank, as a negative control. Mice were also
intravenous injected in the tail vein with 100 ml of 0.1% Evans
blue dye (Anedra, Buenos Aires, Argentina). The presence of blue
color in the skin 15 to 30 min following the injection was
considered a positive cutaneous test.
In vitro evaluation of the allergic state
Specific IgE Detection. Serum specific IgE antibodies were
measured by EAST using the method described by Ceska et al
[40]. Briefly, cyanogen bromide -activated cellulose paper discs
were coupled with CMP (1.75 mg/ml), SP (0.5 mg/ml), or the
recombinant proteins (0.2 mg/ml). Discs were blocked with
0.5 mM ethanolamine, and incubated overnight at 4uC with
50 ml of undiluted serum samples. Then, the assay was developed
as described by Smaldini et al [15].
Specific IgG1 and IgG2a Detection. serum CMP- or SP-
specific IgG1 and IgG2a were measured by ELISA as described by
Smaldini et al [15]. Briefly, microtitre plates were coated with
1 mg/100 ml of either CMP, SP, a, a-T or PA in carbonate-
bicarbonate buffer, pH 9.6. The assay was developed as indicated
[15].
Cytokine Response of Antigen-stimulated Splenocytes. 24 h
following the oral challenge mice were killed, spleens were removed
and cells were isolated. Splenocytes (46106 cells/well) were plated
in complete medium (RPMI-1640 supplemented with 10% FBS,
100 U/ml penicillin and 100 mg/ml streptomycin), and stimulated
for 72 h with CMP (350 mg/ml), SP (200 mg/ml), ConA (5 mg/ml),
a (15 mg/100 ml), a-T (15 mg/100 ml) or PA (15 mg/100 ml).
Supernatants were collected, and cytokines were quantified by
ELISA: IL-5, IFN-c (Invitrogen, Invitrogen Corporation, USA).
Ethics Statement
All experimental protocols of this study were conducted in strict
agreement with international ethical standards for animal exper-
imentation (Helsinki Declaration and its amendments, Amsterdam
Protocol of welfare and animal protection and National Institutes
of Health, USA NIH, guidelines: Guide for the Care and Use of
Laboratory Animals) and were approved by the local Institutional
Animal Care and Use Committee at the School of Animal Science
(University of La Plata). Anesthetized mice (intraperitoneal
injection of 100 mg/kg ketamine and 5 mg/kg xylacine) were
killed by cervical dislocation by experienced research personnel,
which performed it humanely and effectively. All efforts were
made to alleviate suffering during the whole experiment.
For the human sample analysis a written informed consent was
obtained from parents of patients and the project was approved by
the Ethics Committee of the Argentinean Association of Allergy
and Clinical Immunology (February 2012). Sera were obtained
from patients assisted at Hospital San Juan de Dios de La Plata.
Statistical Analysis
All statistical analyses were carried out using GraphPad Prism 5
software. The significance of the difference was determined using
an independent-sample t-test or ANOVA test. A p-value,0.05
was regarded as statistically significant.
Results
Beta conglycinin Alpha Subunit and the Polypeptide
Fragment a-T are Specifically recognized by Different
CMP specific Antibodies
We previously showed that although the soybean variety Raiden
lacks the cross-reactive G4 glycinin, a residual cross-reactivity,
probably due to the 7S seed globulin a-subunit of b-conglycinin
(Gly m 5.0101), was detected [14]. In this work, recombinant Gly
m 5.0101 (a) and a 235 amino acid residue polypeptide fragment
(,27 kDa) containing the three helix and one cupin domain, a-T,
were immunochemically evaluated. Different CMP-specific anti-
bodies were used to assess the cross-reactivity of these soy
components (Figure 1). The amount of different coated antigens
was adjusted in the indirect ELISA to have the same molar
relationship. We found that all sera recognized CMP (100%),
while most of the milk allergic patient sera presented IgE
antibodies that recognized a (86.6%) and a-T (93.3%)
(Figure 1A). The pattern reactivity obtained by immunoblotting
revealed that human and rabbit polyclonal sera recognized caseins
A Soy Peptide Responsible for Allergy in Mouse
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as monomers or aggregates (Figure 1B upper panel), whereas the
1D5 mAb bound a- casein. As it can be seen in the medium panel,
these sera recognized soy components of 30 kDa and higher MW,
corresponding to a, a9, and b subunit of b-conglycinin. The
30 kDa-band may correspond to the processed polypeptide
A5A4B3 of G4 glycinin, previously described as cross-reactive
protein [13,14]. The lower panel shows that recombinant a and a-
T were recognized by the different milk specific antibodies.
We next investigated the specificity of the antigen-antibody
interaction with a sequential competitive ELISA. To enhance the
sensitivity and the detection capacity of the assay, the CMP-
specific antiserum or the mAb were pre-incubated with different
concentrations of soluble inhibitors (reactant proteins). Then,
soluble unbound CMP-specific antibodies were allowed to react
with the coated antigen. The sigmoid shape of the dose-response
curve obtained confirmed the specificity of the Ag-Ab binding
(Figure 2). The binding of the CMP-specific polyclonal antiserum
to the immobilized CMP was 100% inhibited with 3 mg/ml of
soluble CMP, while 50% of inhibition (IC50) was achieved with
0.002 mg/ml CMP and 0.2 mg/ml a (Figure 2A). On the other
hand, when any of the recombinant polypeptides was coated to the
solid phase, sigmoid curves were obtained with a lower dilution of
the polyclonal antiserum (1:6,000), as compared with that used
when CMP was coated to the solid phase. This assay rendered an
IC50 of 0.1 mg/ml for CMP (Figure 2B). Taken together, and not
surprisingly, CMP binding to milk-specific antibodies was more
efficiently inhibited with CMP than with soybean components.
However, the recombinant soy polypeptides could specifically
inhibit the binding of the milk-specific antibodies to the coated
homologous antigen. Figure 2C shows the sigmoid curves obtained
with the a-casein-specific mAb used in the immunoblottings
depicted in figure 1B. More than 95% of inhibition was achieved
with a minimum of 0.01 mg/ml CMP as soluble inhibitor, while
none of the other proteins could achieve such values at the range
of the concentration assessed. The IC50 was 0.0015 mg/ml for
CMP, 0.019 mg/ml for a-T and 0.13 mg/ml for a. A non-related
control protein (BSA) rendered a constant basal inhibition of less
than 10% in all assays (Figures 2A and C).
Kinetic and Equilibrium Constants between a-casein-
specific mAb 1D5 and Bovine a-casein and the
Recombinant Soybean Proteins
The 1D5 mAb was employed to analyse the kinetic, equilibrium
and affinity constants with a-casein and soy components (Table 1).
According to the affinity constant (KA) value of 1.18610
7 M21 for
a-casein we consider that this antibody recognizes with a medium
affinity its identity antigen. Interestingly, similar values were found
for a and a-T. However, a lower KA (4.06610
6 M21) was
measured for PA, which may be due to the smaller size of this
fragment, and hence to fewer contacts with the antibody, as
compared to a and a-T. Besides, a discrete increase in association
constant (kass) was observed for a as compared with its specific
antigen, a-casein. This result may be explained by a different
conformation or a different charge on the surface of the epitope in
a, which produced more productive contacts with the 1D5 mAb.
Peptides containing Cross-reactive Epitopes were
identified in a-T
Once we have detected that a-T contained B epitopes, 24
overlapping 15-mer peptides with 5 amino acid overlaps were
synthesized on modified cellulose paper covering the whole
sequence of a-T. Spots were probed with different CMP-specific
antibodies to identify IgE and IgG cross-recognized zones
(Figure 3). We observed similar reactivity patterns with the rabbit
polyclonal antiserum and human sera: spots 1, 2 and 9 exhibited
strong human IgE binding, while spots 1 and 2 showed a strong
reactivity with the rabbit antiserum. We observed a faint reactivity
on spots 16 and 22 with the pooled sera, and, on spots 9 and 12
with the rabbit antiserum. Peptides on spots 14 and 23 were only
recognized by the rabbit antiserum. On the other hand, the a-
casein-specific monoclonal antibody recognized peptides on spots
1, 2, 9, 12, 16 and 22 with high or middle intensity, and, unlike
human IgE and rabbit IgG, it also recognized peptides on spots 4,
10 and 14. In summary, 10 peptides along the aminoacidic
sequence of a-T were recognized by the different CMP-specific
antibodies, indicating that cross-reactivity is not due to a single
epitope (spots marked with grey boxes).
Furthermore, we calculated the net charge of the peptides and
remarkably we found that reactive peptides are all positive, but
peptide 14 (charge 22.2), whereas non reactive peptides are all
negatively charged at pH 7.5 (Figure S1 A).
In Silico Analysis showed that Conformational and Linear
Epitopes are implicated in Cross-reactivity
In agreement with the epitope mapping of a-T done in vitro
(Figure 3), sequence alignment analysis in figure 4A and figure S2
showed a high aminoacidic similitude (hits) in those positions
where positive spots were obtained in the overlapping assay. High
hit values along the a-T sequence where observed around amino
acid positions 20 and 40 (region corresponding to positive spots 2
and 4), 77 and 90–100 (spots 9 and 10), 150 (spot 16), and 220
(spots 22 and 23). In figure 4B the sequence of a-T is depicted
along with the peptides analyzed in the overlapping assay and the
secondary structure predicted with different bioinformatics tools.
As it can be observed, the selected PA peptide contains the region
with the highest hits (peptides 9, 10 and 12).
The in silico predicted secondary structure (Figure 4B) showed
that PA contains a-helix and b-sheet conformations. PN peptide
was proposed as a control peptide since no secondary structure
was predicted in this sequence and it contains low hit regions.
In addition, the amino acid composition was analyzed and we
found hydrophilic (serine, asparagine, alanine and lysine) and
hydrophobic amino acids (phenylalanine, isoleucine and leucine)
as the most frequent amino acids in the different positive peptides
in the overlapping assay of a-T. PA contains a compositional bias
to hydrophilic amino acids such as glutamic acid (E), serine (S),
Figure 1. Immunochemical cross-reactivity. A) Detection of specific human serum IgE antibodies by indirect ELISA. Microtiter plates
were coated with CMP, SP, recombinant a-subunit of b-conglycinin ‘‘a’’ or a-T, and sequentially incubated with sera of CMA patients and anti-human
IgE specific conjugate. 15/15 sera contained IgE antibodies specific for CMP, 13/15 sera contained IgE antibodies specific for a and 14/15 sera
contained IgE antibodies for a-T. B) SDS-PAGE and immunoblotting of CMP and SP. SDS-PAGE was performed under non reducing conditions
for CMP (upper panel), SP (middle panel), and purified recombinant a and the a-T fraction (lower panel). Immunoblottings were developed with
patient sera containing milk-specific IgE antibodies or control sera (from non-allergic patients) (1:4), CMP-specific rabbit polyclonal antiserum
(1:1,000), and a-casein-specific monoclonal antibody (1D5 mAb 1:1,500). CMP: Cow’s milk protein, cas: caseins, SP: soybean protein, G: 11S glycinin
subunits; b-conglycinin subunits are indicated as a, a9 and b. M: Molecular masses are given on the left in kilo Daltons (kDa).
doi:10.1371/journal.pone.0082341.g001
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Figure 2. Sequential competitive ELISA with the CMP-specific rabbit polyclonal antiserum and 1D5 mAb. Microtiter plates were coated
with CMP (1 mg/well) (A and C), a (0.1 mg/well) or a-T (0.1 mg/well) (B). CMP-specific polyclonal antiserum (A: 1:200,000; B: 1:6,000) or a-casein-
specific mAb (C: 1:300,000) were pre-incubated with different inhibitors at several concentrations and then added to Ag-coated wells. Then the
appropriate conjugated secondary antibodies were added and the color was developed.
doi:10.1371/journal.pone.0082341.g002
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lysine (K) and arginine (R) in the a-helix secondary structures
(Figure S2).
Since conformational epitopes may be involved in this cross-
recognition, homology models of a, a-T and PA were built
(Figure 5A). As it can be seen in figure 5A the a-helix and b-sheet
conformations are highly critical for the spatial distribution of all
components. It became evident that peptides containing the cross-
reactive domains are surface exposed and accessible to the solvent
(Figure 5B).
The 3D models obtained were built using the structure of the
soy a9 subunit of b-conglycinin from soybean (PDB 1UIK), which
shows 90% identity with a subunit of b-conglycinin, as derived
from fold assignment. The best structural model was evaluated
using ProsaII and a Z-score = 27, indicating a high reliability.
According to the peptide reactivity and localization on the
surface of the a subunit of b-conglycinin, three putative epitopes
can be proposed (Figures 5B I and II). The region 1 would be
contained in the PA fragment, while regions 2 and 3 could be
structurally close, but on the opposite side of PA in the molecule.
Analyzing the secondary structure of the three immune reactive
regions, and taking into account homology modeling results
(Modeller) and the superficial residues visualized by PyMol, we
found that a-helices, b-strands and connecting loops are relevant
for the region 1-containing PA, which includes the positive spots 9,
10 and 12 of the overlapping assay. Instead, region 2 (contains
P16, P22 and P23) and region 3 (contains P1, P2 and P4) would be
mainly composed of superficial connecting loops. Furthermore, we
studied the electrostatic potential on the surface of the three
reactive regions using the PBEQ-Solver interface [35] on the web.
The surface charge of the region 1 is positive (Figure S1B I)
suggesting the predominance of electrostatic interactions with
antibodies. On the other hand, the analysis of the electrostatic
potential of the accessible solvent surface of region 2 and 3 (located
on the opposite side of the molecule) (Figure S1B II) showed
different features which may imply different interactions with
antibodies. As judge for the electrostatic potential, surface epitopes
contained in region 2 may be recognized by antibodies through
hydrophobic or non-ionic interactions, while for the region 3
hydrophobic forces may be mainly involved, with a component of
electrostatic bonds.
Immunoassays showed the Presence of Linear and
Conformational Epitopes on PA
Immunoblotting with different cow’s milk-specific antibodies
was assessed to validate the cross-reactivity of recombinant PA and
PN. The immunoblotting pattern reactivity observed for PA
indicates the presence of IgG- and IgE-binding epitopes, whereas
PN showed no reactivity (Figure 5C). Elucidation of conforma-
tional epitopes involved in the cross-recognition of PA was assessed
by dot-blot under different denaturing conditions (Figure 5D).
Peptides heated or treated with urea and SDS showed a lower
intensity when membranes were revealed with the CMP-specific
antibodies (human sera containing IgE, the rabbit polyclonal
antiserum and the mAb specific for a-casein), as compared to
untreated PA. However, the reactivity observed with the rabbit
polyclonal antiserum with DTT- and urea-treated PA led us to
speculate that this antiserum also contains milk-specific antibodies
capable of recognizing linear IgG epitopes.
In Vivo and In Vitro Cross-reactivity of Soybean
Components was confirmed with a CMA Murine Model
To further investigate the clinical relevance of the immuno-
chemical cross-reactivity described, orally sensitized Balb/c mice
with CMP were challenged with soy proteins (Figure 6A). Signs
and symptoms were observed and scored on a scale from 0 to 5
according to the criteria shown in Table 2. We found that milk
sensitized mice developed hypersensitivity symptoms immediately
following the oral exposure to soy (SP, a, a-T and PA) or milk
components (CMP and b-lg) (Figure 6A and B). No symptoms
were observed in sensitized mice exposed to OVA, or in sham
mice exposed to the different antigens. Remarkably, the sl
challenge with individual proteins triggered immediate clinical
signs (Figure 6B), thus reflecting the compromise of the mouth
mucosa in animals that were intragastrically sensitized. These
findings correlated with the high serum specific IgE levels
(Figure 6C) and positive skin tests (Figure 6D) found in milk
allergic mice injected with a, a-T and PA. Positive skin tests were
also obtained with CMP and SP (pictures not shown). In addition,
control mice rendered negative skin tests when injected with CMP,
SP or soy recombinant components (pictures not showed). Every
mice were injected with saline as control in the contra-lateral side
and in all cases the reaction was negative (one is showed in
Figure 6D). Moreover, Th2-associated IgG1 antibodies that were
induced during the sensitization phase with cholera toxin, also
recognized the different soy components. Specific IgG2a remained
undetectable during the experiment (data not showed), indicating
no Th1 induction during the sensitization phase.
Finally, we found an increased secretion of IL-5 by spleen cells
stimulated with CMP, SP, a and a-T (Figure 6E). PA showed a
slight increase in the production of this Th2-associated cytokine,
while IFN-c remained low, as expected. These findings clearly
indicate that CMP-specific T cells elicited during the sensitization
phase can be in vitro stimulated with soy components.
Discussion
The characterization of the cross-reactivity between milk and
soy allergens may shed light on the structural and immunologic
Table 1. Kinetic and equilibrium constants for complexes formed by a-casein, a subunit of b-conglycinin (a), a-T and PA with the
1D5 mAb, specific for a-casein.
kass (M






1.05610460.146104 8.886102460.2261024 1.18610760.136107 8.446102861.4861028
a 1.89610460.186104 9.796102461.4761024 1.93610760.226107 5.186102860.6061028
a-T 3.14610460.446104 2.706102360.4061023 1.16610760.066107 8.606102860.4461028
PA 6.92610360,486103 1.706102361.1561023 4.06610662.756106 2.466102761.6761027
kass: Association constant, kdiss: Dissociation constant, KA: Affinity constant, KD: Equilibrium Dissociation constant.
doi:10.1371/journal.pone.0082341.t001
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relationships between phylogenetically unrelated allergens. Our
recent studies show that members of the 11S (Gly m 6) and 7S (Gly
m 5) globulin storage soy proteins are cross-reactive allergens with
bovine caseins [13–15]. The immunochemical cross-reactivity
described has been biologically confirmed using an IgE-mediated
mouse model of food allergy with mice exclusively sensitized to
CMP [15]. This finding highlights the potential clinical relevance
of this phenomenon in allergic patients, although limitations are
obvious with conclusions extrapolated from animal models.
However, we consider they provide a useful biological tool when
ethics is concerning, and in situations in which co-sensitization in
patients is almost impossible to disprove. There are some studies
reporting the occurrence of clinical intolerance to soy-based
formula in milk allergic patients without previous sensitization to
soy allergens [9,10]. Although they show that it occurs in a small
proportion of patients (,15%), this intolerance is a clinical
common concern in our population. Milk allergic patients may
develop hypersensitivity reactions following accidental exposure to
soy after the ingestion of soy-containing foods, or during the
restrictive treatment with soy-based formula.
In this study, we have focused on investigating shared B and T
epitopes of Gly m 5 with bovine caseins, which are relevant
allergens of soy and milk respectively [11,20]. Of note, the soy
recombinant components were recognized as soluble antigens by a
rabbit CMP-specific polyclonal antiserum and the a-casein specific
monoclonal antibody in a competitive ELISA. These findings
discard the possibility of neo epitopes created during the coating of
antigens to the solid phase as responsible for this cross-reactivity
Figure 3. Epitope mapping of a-T. SPOTs array depicting the overlapping 15-aminoacid peptides covering the complete sequence of a-T, and
probed with two different pools of serum from cow’s milk allergic patients, a rabbit CMP-specific polyclonal serum and the 1D5 a-casein-specific
mAb, followed with the appropriate conjugated secondary antibodies. Positive spots are shaded in grey boxes and recognized amino acids are
bolded in the sequence depicted for spotted peptides.
doi:10.1371/journal.pone.0082341.g003
Figure 4. Schematic localization of the identified spots along the a-T sequence and sequence alignment analysis. A) Analysis of the
sequence alignment of a-T with IgE epitopes in bovine caseins (IEDB) shown as hit distribution of amino acid similitude per position along the
sequence of a-T. Positions of a-T with high hit values (black columns) correlate with positive spots of the overlapping assay (spots 9, 10 and12); B)
The sequence of a-T (1–234 aa) is depicted along with overlapped peptides, PA and PN (305–539 aa correspond to a). In silico predicted alpha-helix
(white ovals) and beta-sheet (black arrows) zones are indicated. PA contains the amino acid positions with the highest hits and the a-helix and b
strand secondary structures.
doi:10.1371/journal.pone.0082341.g004
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and confirm that a and a-T contain cross-reactive B epitopes. This
assay rendered a higher IC50 for a than that for CMP with the
polyclonal and monoclonal antibodies (150 and 86 times respective-
ly), which is reasonable since these antibodies are primary specific for
milk components. These results and the shape of the dose-response
curves indicate that the antigen-antibody interaction is specific, that
the a protein and its fraction a-T bear cross-reactive epitopes with
bovine a-casein, and that a restricted population of CMP-specific
antibodies specifically recognized B epitopes in a and a-T
polypeptides. These findings were further characterized with the
biosensor binding assay, which showed that a-casein, a and a-T
present similar affinity constant to the a-casein-specific mAb. The
higher kass value found for a-T as compared with that for a and a-
casein can be due to stronger favourable contacts in the interface
formed between mAb 1D5 and a-T. However, the kdiss value means
that this complex is more unstable than those formed with a and a-
casein. Likewise, the smaller kass value found for PA as compared to
the other components analyzed can be explained by lower contacts
with 1D5, which may be due to its smaller size and conformational
changes. As expected, we found medium affinities for this monoclonal
antibody with different cross-reactive antigens, which may reflect an
overall approach to understand the cross-reactivity implicated in a
hypersensitivity reaction. Recently, and using synthetic allergens, it
has been shown that IgE antibodies do not necessarily need to have a
high affinity with its specific antigen to trigger mast cell degranulation
[41]. In this study we have shown that even a 64 amino acid residue
peptide of moderate affinity triggers a specific allergic response in milk
allergic mice, thus indicating that it can activate sensitized cells.
To gain more insight into the molecular feature of this cross-
reactivity we next characterized B epitopes (IgG and IgE) on
Figure 5. In silico and in vitro analysis of a, a-T and PA. A) Homology model obtained using the Modeller and visualized by PyMOL of a-subunit
of b-conglycinin, a-T and PA, based on NCBI Conserved Domain Search results with a9 subunit as template (a-helices are shown in blue and b-sheets
as dark grey arrows on the structure). B) Surface representation of positive overlapped peptides marked in different colors according to the intensity
of the reaction (from pale yellow to red); I and II correspond to opposite sides of the a molecule. Positive peptides localized on the surface of the
molecule seem to converge in three regions or putative epitopes. The remaining part of the molecule is represented in transparent spheres showing
the secondary structure. C) SDS-PAGE of recombinant PA and PN and immunoblotting developed with 1D5 a-casein-specific mAb and a
representative serum of CMA patients. Alpha-s1 casein was used as positive control (Molecular masses are shown on the left as kDa). D) Dot-blot of
recombinant treated and untreated PA revealed with a pool of CMA patient sera, a-casein-specific mAb and CMP-specific polyclonal rabbit antiserum.
Denaturing conditions consisted on: 0.1M DTT solution, 6M urea or 100uC for 10 minutes. Cas: Alpha-s1 casein.
doi:10.1371/journal.pone.0082341.g005
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different peptides of a (a-T and PA) using overlapping synthetic
peptides, recombinant allergenic fragments and unfolded frag-
ments. Besides, the overlapped peptide scanning revealed that
cross-reactivity is not due to a unique shared epitope. The
overlapping peptide assay showed that the epitope-bearing 15-mer
peptides contain 33.8% of hydrophobic (A: alanine, F: phenylal-
anine and L: leucine), 29% of neutral hydrophilic (S: serine and N:
asparagine) and 9.6% of charged hydrophilic aminoacids (K:
lysine, E: glutamic acid) with a positive net charge, suggesting that
different ways of antibody-antigen recognition may be possible in
this type of cross-reactivity (Figure S1). Since the combining site of
an antibody may present different zones with different charges,
and furthermore, different conformers of the paratope can be
found in unbound antibodies exhibiting different surfaces of
interaction with antigens in this regard, a single antibody can
interact with different epitopes even on the same antigen. In the
particular case of the PA, which is mainly positively charged, the
interactions with antibodies are expected to be electrostatic with a
net negatively charged paratope. Regarding epitopes present in
the region 2, the type of interactions are mainly hydrophobic, but
analyzing epitopes in the region 3 those interaction could be a
combination of hydrophobic and electrostatic ones. Thus, the
studied cross-reactivity implies a more complex interpretation than
just considering the presence of a unique and shared epitope.
The in silico analysis for prediction of cross-reactive epitopes,
secondary structure and modeling of Gly m 5 indicated that PA
contains cross-recognized conformational and linear epitopes that
are exposed on the surface of the allergen to interact with
antibodies. Then, IgG and IgE cross-reactive epitopes were
confirmed in PA using different milk-specific antibodies and
immunoassays. It has been described that the feature of the
epitope in caseins is critical for the history of milk allergy in allergic
patients [42–44], and the recognition of conformational epitopes is
a predictive factor for a later acquisition of tolerance to CMP.
Therefore, monitoring the reactivity of serum antibodies against
PA might constitute an additional prognostic tool for achievement
of immune tolerance in patients. Although the disruption of
dominant epitopes in PA using chaotropic agents provided
preliminary data, further investigations with structural biology
techniques such as X-ray crystallography and nuclear magnetic
resonance are necessary to visualize these conformational cross-
reactive epitopes. In this sense, the combination of different
mapping techniques with the visualization of the 3D models is
needed to assess the structural integrity of allergens. Food antigens,
which have mainly linear epitopes following food processing or
digestion, also contain conformational epitopes that can be
affected by food processing, thus interfering with the conforma-
tion, IgE binding activity and hence the allergenicity.
The use of different sequence databases of caseins allergenic
epitopes provided no information of shared sequences with the soy
component studied here. However, the sequence database
obtained by us, using the describe techniques above, provided of
several peptides of a-subunit of b-conglycinin that presented
homology with milk caseins and their cross-reactivity was in vitro
confirmed. Therefore, based on in silico and experimental data we
have selected a peptide from the sequence of a-T (PA) that
matched the identified IgE-binding epitopes in caseins [42,45,46].
Fu et al [47] identified IgG sequential and solvent-exposed
epitopes (185–231) in the N-terminus domain of the a-subunit of
the b-conglycinin, which is not coincident with the epitope here
described in the C-terminus domain. Therefore this peptide of Gly
m 5 represents a new IgE-binding epitope that occurs in a
conformational region of the protein exposed to the solvent.
In this study, the combination of bioinformatics tools for
prediction of epitopes, secondary structure, surface electrostatic
charge, sequence alignment, molecular modeling and visualization
of immunodominant regions in 3D modeled molecules, with
immunochemical techniques (immunoblotting, indirect ELISA
and competitive ELISA), SPR biosensor and in vivo experiments,
allowed us to strongly demonstrate the existence of cross-reactivity
between Gly m 5 and caseins. Besides, we have selected a
candidate peptide that contains linear and conformational B, and
T epitopes, which could be easily rendered hypoallergenic for a
potential and safe therapeutic treatment.
The clinical symptoms elicited after the sublingual challenge with a,
a-T and PA, and the positive skin prick tests confirmed the presence of
at least two IgE-binding epitopes on the Gly m 5.0101 soy fractions.
Of note, the presence of linear T epitopes could be evidenced when
Figure 6. In vivo cross-reactivity assessed in a food allergy mouse model. A) Schematic representation of the experimental protocol: BALB/c
mice were subjected to weekly intragastric sensitization with cholera toxin and CMP from day 0 through day 35. Challenge was performed at day 45
by ig administration of proteins (CMP, SP or OVA). Control mice only received CMP and then they were challenged with the different antigens.
Symptoms were observed 30 min following the oral challenge and scored according to Table 2. B) Clinical scores assigned to symptoms observed
30 min following the sublingual challenge with 10 mg of b-lg, a, a-T, PA or OVA. C) Specific IgE and IgG1 in serum of milk-sensitized and control mice
were assessed by EAST or indirect ELISA at day 45, respectively (mean values 6 SEM). D) Cutaneous test performed in sensitized mice subcutaneously
injected with 10 mg of antigens (a, a-T or PA) in the right flank and with saline in the left flank. The presence of blue color in the skin within minutes
was considered a positive cutaneous test. E) Levels of IL-5 and IFN-c assayed on stimulated splenocyte supernatants by ELISA (mean values 6 SEM).
Results correspond to a single experiment with five mice per condition, representative of three separate experiments that gave similar results.
Statistically significant differences are denoted as starred values (*) ***p,0.005, **p,0.01, *p,0.05.
doi:10.1371/journal.pone.0082341.g006
Table 2. Clinical scores assigned to symptoms triggered following the oral or sublingual challenge.
Score Symptoms
0 No symptoms
1 Scratching and rubbing around the snout and head
2 Puffiness around the eyes and mouth, pilar-erecti, diarrhea, reduced activity and/or decreased activity with increased respiratory rate
3 Respiratory distress, cyanosis around snout and tail
4 No activity upon stimuli, convulsion
5 Death
doi:10.1371/journal.pone.0082341.t002
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spleen cells were stimulated with these fractions, with the secretion of
IL-5. The ability of a, a-T and mainly PA for T cell activation
encourage us to propose them in a potential mucosal therapy for
tolerance induction in patients with milk and/or soy allergy.
As a conclusion, using in vitro, in vivo and in silico approaches we
have identified a peptide of Gly m 5 that contains B and T cross-
reactive epitopes with bovine casein. This information sheds light on
the characterization of this relevant soybean allergen, and may
provide a molecular explanation for the complex IgE cross-reactivity
between the phylogenetically unrelated milk and soy allergens. This
phenomenon may explain the secondary soy allergy elicited during
the treatment of some cow’s milk allergic patients. Finally, this
knowledge may be exploited to develop a mucosal tolerizing
immunotherapy using PA for intervention in soy and milk allergy.
Supporting Information
Figure S1 Electrostatic and charge analysis of a-T. A) pI and
charge at pH = 7.5 for peptides of the overlapping assay estimated
with the Protein Calculator v3.3 (http://www.scripps.edu/
,cdputnam/protcalc.html). B) Electrostatic potential surface on
the a subunit of b-conglycinin showing I) region 1, which contains
the PA fragment, and II) regions 2 and 3. Note that the region 1 is
mostly positively charged, region 2 is mostly hydrophobic and
region 3 is hydrophobic and slightly positively charged.
(TIF)
Figure S2 Multiple sequence alignment between sequences of a-
T and epitopes on bovine casein peptides. A total of 73 peptides of
a-S1 (1–55), a-S2 (56–63), b (64–67) and k (68–73) bovine caseins,
described as T and/or B epitopes (IEDB, (http://www.
immuneepitope.org/) were aligned with a-T sequence using the
ClustalW2 server (http://www.ebi.ac.uk/Tools/msa/clustalw2/).
Common amino acids are shaded in red on casein peptide
sequences, or in grey in the a-T sequence. Blue rectangles delimit
the highest frequencies of similitude observed (which correspond
to the high hit values in Figure 4 A). Green and yellow boxes
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